Sino Medical Science...
SHSE:688108
¥ 20,30
+ ¥0,57 (2,89%)
20,30 ¥
+¥0,57 (2,89%)
End-of-day quote: 03/27/2026

Sino Medical Sciences Technology Stock Value

Analysts currently rate SHSE:688108 as sf_Data Unavailable.
-

Sino Medical Sciences Technology Company Info

EPS Growth 5Y
0,00%
Market Cap
¥8,48 B
Long-Term Debt
¥0,14 B
Annual earnings
N/A
Dividend
¥0,00
Dividend Yield
0,00%
Founded
2007
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Sino Medical Sciences Technology’s Price Target has risen from ¥14,00 to ¥14,00 - a 0,00% increase. One analysts predict that Sino Medical Sciences Technology’s share price will fall in the coming year, reaching ¥0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

Sino Medical Sciences Technology Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Medical Technology:** 60% **Diagnostic Devices:** 25% **Health Services:** 15% **TOP 3 Markets:** **China:** 50% **USA:** 20% **Europe:** 15% Sino Medical Sciences Technology Inc. generates the majority of its revenues from the medical technology sector, followed by diagnostic devi...
At which locations are the company’s products manufactured?
**Production Sites:** Tianjin, China Sino Medical Sciences Technology Inc. mainly produces its medical devices and technologies in Tianjin, China. This strategic location allows the company to benefit from the well-developed infrastructure and logistical advantages of the region. Tianjin is known f...
What strategy does Sino Medical Sciences Technology pursue for future growth?
**Focus on Research and Development:** Increase in R&D spending by 20% (2025) **International Expansion:** Entry into three new markets in Southeast Asia (2025) **Product Diversification:** Introduction of two new product lines in the field of medical technology (2024) Sino Medical Sciences T...
Which raw materials are imported and from which countries?
**Commodities/Materials:** Medical plastics, stainless steel, silicone **Countries of origin:** USA, Germany, Japan, China Sino Medical Sciences Technology Inc. imports a variety of commodities and materials necessary for the production of their medical devices and products. These include medical...
How strong is the company’s competitive advantage?
**Market share in China:** 12% (2025, estimate) **Research and development ratio:** 8.5% of revenue (2025) **Patent portfolio:** Over 200 active patents (2025) Sino Medical Sciences Technology Inc. has a significant competitive advantage in the field of medical technology, especially in China....
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** Estimate 30-40% (2026) **Insider Buys/Sells:** No specific data available (2026) The institutional investor share in Sino Medical Sciences Technology Inc. is estimated to be around 30-40%. This corresponds to a typical pattern for companies listed on the Shanghai...
What percentage market share does Sino Medical Sciences Technology have?
**Market share of Sino Medical Sciences Technology Inc.:** 8% (estimated for 2026) **Top competitors and their market shares:** 1. **Medtronic plc:** 15% 2. **Boston Scientific Corporation:** 12% 3. **Abbott Laboratories:** 10% 4. **Edwards Lifesciences Corporation:** 9% 5. **Sino Medical Sciences...
Is Sino Medical Sciences Technology stock currently a good investment?
**Revenue Growth:** 18% (2025) **R&D Expenses:** 12% of revenue (2025) **Market Share in China:** 25% (2025) Sino Medical Sciences Technology Inc. achieved a revenue growth of 18% in 2025, driven by strong demand for their medical devices and innovative technologies. The company continuously in...
Does Sino Medical Sciences Technology pay a dividend – and how reliable is the payout?
**Dividend:** No payout (as of 2026) Sino Medical Sciences Technology Inc. has not paid any dividends so far. The company is in a growth phase and reinvests its profits in research and development as well as in expanding its business activities. This is typical for companies in the medical technolo...
×